FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

391812009: Bambuterol hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2693748010 Bambuterol hydrochloride en Synonym Active Entire term case insensitive SNOMED CT core module
2735056015 Bambuterol hydrochloride (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bambuterol hydrochloride Is a Substance with beta-2 adrenergic receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Bambuterol hydrochloride Is a Bambuterol false Inferred relationship Existential restriction modifier
Bambuterol hydrochloride Has disposition Beta adrenergic receptor agonist false Inferred relationship Existential restriction modifier
Bambuterol hydrochloride Has disposition Beta-2 adrenergic receptor agonist true Inferred relationship Existential restriction modifier
Bambuterol hydrochloride Is a Ethanolamine false Inferred relationship Existential restriction modifier
Bambuterol hydrochloride Is modification of Bambuterol true Inferred relationship Existential restriction modifier
Bambuterol hydrochloride Is a Ethanolamine and/or ethanolamine derivative true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Bambuterol adverse reaction Causative agent False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Allergy to bambuterol Causative agent False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol hydrochloride Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely bambuterol hydrochloride 10 milligram/1 each conventional release oral tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely bambuterol hydrochloride 20 milligram/1 each conventional release oral tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely bambuterol hydrochloride 10 milligram/1 each conventional release oral tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely bambuterol hydrochloride 10 milligram/1 each conventional release oral tablet Has basis of strength substance True Bambuterol hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely bambuterol hydrochloride 20 milligram/1 each conventional release oral tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely bambuterol hydrochloride 20 milligram/1 each conventional release oral tablet Has basis of strength substance True Bambuterol hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely bambuterol hydrochloride 10 milligram/1 each conventional release oral tablet Has precise active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely bambuterol hydrochloride 20 milligram/1 each conventional release oral tablet Has precise active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier 2
Product containing precisely bambuterol hydrochloride 10 milligram and montelukast (as montelukast sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Bambuterol hydrochloride Inferred relationship Existential restriction modifier 2
Bambuterol hydrochloride 10mg tablet - product Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol hydrochloride 20mg tablet - product Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 20mg tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (AstraZeneca) Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 20mg tablets (AstraZeneca) Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol 10mg tablets 28 tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol 20mg tablets 28 tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (AstraZeneca) 28 tablet 4 x 7 tablets Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 20mg tablets (AstraZeneca) 28 tablet 4 x 7 tablets Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 20mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol 20mg tablets 30 tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol 10mg tablets 30 tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 20mg tablets (Sigma Pharmaceuticals Plc) 30 tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (Sigma Pharmaceuticals Plc) 30 tablet Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (AstraZeneca) Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (AstraZeneca) 28 tablet 4 x 7 tablets Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol 10mg tablets 30 tablet Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely bambuterol hydrochloride 10 milligram/1 each conventional release oral tablet Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol 10mg tablets 28 tablet Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (Sigma Pharmaceuticals Plc) 30 tablet Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 20mg tablets (AstraZeneca) Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely bambuterol hydrochloride 20 milligram/1 each conventional release oral tablet Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 20mg tablets (Sigma Pharmaceuticals Plc) 30 tablet Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol 20mg tablets 28 tablet Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 20mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambuterol 20mg tablets 30 tablet Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 20mg tablets (AstraZeneca) 28 tablet 4 x 7 tablets Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient False Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier
Bambec 10mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Bambuterol hydrochloride Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start